Our results show that there is abnormally elevated IDO expression in patients with first-episode drug-naive schizophrenia, and IDO expression correlates with negative symptoms of schizophrenia and the levels of various pro-inflammatory cytokines in peripheral blood. The gene discussed is IDO1; the disease is schizophrenia.